Oxazolidine derivative ameliorates diet-induced non-alcoholic fatty liver disease by modulating PI3K/AKT signaling and metabolic homeostasis.
The most common type of chronic liver disease is non-alcoholic fatty liver disease (NAFLD), which has become a significant worldwide health concern. Western eating patterns are characterized by diets high in fats and sugar, which disrupt redox balance, promote inflammatory responses, and impair normal liver function. E...